Frontlight ResearchEarly access
Trial site
The Liver Institute at Methodist Dallas
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)6 trials
- Liver cirrhosis3 trials
- Obesity1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Genfit1 trial
- Hanmi Pharmaceutical Company Limited1 trial
- Inventiva Pharma1 trial
- Madrigal Pharmaceuticals, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 13 Nov 2026